The Anticancer Drug Development Guide provides a comprehensive overview of the multifaceted process involved in bringing new cancer therapies from the laboratory to the patient. It details the critical stages of preclinical research, clinical trials, and regulatory approval, highlighting the challenges and innovations within each phase. The book aims to equip researchers, clinicians, and industry professionals with the knowledge necessary to navigate the complex landscape of oncology drug development.

This guide is recognized as a valuable resource for professionals engaged in the development of cancer drugs. Its structured approach covers the essential scientific, clinical, and regulatory aspects of the field. The book is likely to be utilized by researchers, pharmacologists, and clinicians seeking a thorough understanding of the drug development lifecycle in oncology.